🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8685396

Monoclonal antibodies that neutralize anthrax protective antigen (PA) toxin

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680056

Antiproliferative factor and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680066

Methods for determining and inhibiting rheumatoid arthritis associated with the BRAF oncog

The United States of America as represented by the Development of Veterans Affairs · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680065

Oligonucleotides of human endogenous retrovirus 9 (ERV-9) long terminal repeat (LTR) and m

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8680046

Inhibitors of viral integrase and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673316

Avirulent, immunogenic flavivirus chimeras

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673888

Depsipeptide for therapy of kidney cancer

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673629

Recombinant Rift Valley fever (RVF) viruses and methods of use

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673333

Cross-linked polymer matrices, and methods of making and using same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8673292

Pure populations of astrocyte restricted precursor cells and methods for isolation and use

THE GOVERNMENT OF THE UNITED STATES OF AMERICA · Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663968

Simian T-cell lymphotropic virus

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8664183

SPANX-B polypeptides and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8663622

Recombinant vaccine viruses expressing IL-15 and methods using the same

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658694

Buffer solutions having selective bactericidal activity against gram negative bacteria and

United Therapeutics Corporation · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652458

Tissue graft with non-aligned fiber matrix retains mesenchymal progenitor cells on the non

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8653137

Buffer solutions having selective bactericidal activity against gram negative bacteria and

United Therapeutics Corporation · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652787

Use of ERBB4 as a prognostic and therapeutic marker for melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652512

Nebulized liposomes for the pulmonary application of drug compounds

United Therapeutics Corporation · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647633

Recombinant F1-V plague vaccine

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8647818

Molecular scaffolds for HIV-1 immunogens

The United States of America, as represented by the Secretary, Department of Health and Human Services (Hereinafter the Government) Office of Technology Transfer, National Institutes of Health · Granted Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642048

Multiple antigenic peptides immunogenic against Streptococcus pneumonia

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8636997

Method of treating multiple sclerosis with interferon-beta and an IL-2R antagonist

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637560

Imidazolidinone compounds, methods to inhibit deubiquitination and methods of treatment

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637310

Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted